Make your voice heard at the virtual Externally-Led Patient-Focused Drug Development (EL-PFDD) meeting on pemphigus and pemphigoid (P/P). The meeting will bring together patients and care partners, U.S. Food and Drug Administration (FDA) representatives, pharmaceutical companies, doctors, and P/P researchers.